Delays in a clinical trial process can have serious downstream consequences, such as missing a go-to-market window or preventing life-changing solutions from reaching the people who need them as soon as possible. Here are five tips to reduce the risk of database delays.
Medrio is dedicated to making the clinical trial journey easier by creating thoughtful UX designs that emphasize what’s most important and lead to better participant outcomes. Discover how Medrio provides users with streamlined technology solutions for their clinical trials, as well as tips on improving the participant experience.
Adopting ePRO in early-phase trials can revolutionize data collection, reduce participant burden and increase the accuracy of results. Not only does this improve patient care, but it also provides commercial advantages to sponsors.
Medical device organizations aim to reduce development time by 25% in the next five years. The adoption of ePRO can help make this goal a reality.
Global medical device maker Nevro successfully integrates Medrio EDC and ePRO to transition from paper to digital data collection.
The use of multimedia, including videos, animations, or interactive graphics in clinical trials is growing. Although its impact on the success of clinical trials is not yet fully understood, studies have shown that it can improve participant engagement, comprehension, and retention of study information.
Healthcare reimbursement is starting to use patient-reported outcomes as proof that a drug or treatment improves the quality of life enough to warrant the cost.
CROs face growing pressure to differentiate themselves. Myths about sponsor expectations and priorities surrounding eClinical technology can cause CROs to lose bids.
When engaging CROs, sponsors are increasingly prioritizing performance excellence and replicable operating standards.
Protocol amendments are inevitable, but choosing the right RTSM partner can help you navigate study changes with speed and agility.
With increasing regulatory requirements for the inclusion of patient-reported outcomes in study data, maintaining the status quo in PRO collection can have costly consequences.
Participant education is a critical part of informed consent and one that is easy to improve by leveraging established patient education best practices. Medrio CEO Nicole Latimer discusses some of the most successful approaches she has seen in her career:
Sign up to have our the latest insights delivered to your inbox.
